These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19423228)

  • 21. [Extensive fibromata pendulantia. Hydrosurgery as a therapy option using the Versajet technique].
    Bozkurt A; Fuchs PC; Dunda E; Rübben A; O'Dey DM; Tsolakidis S; Boecker A; Merk HF; Pallua N
    Hautarzt; 2012 Aug; 63(8):640-3. PubMed ID: 22851295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis: wraparound technique in a 17-month-old girl.
    Bannasch H; Kontny U; Krüger M; Stark GB; Niemeyer CM; Brandis M; Horch RE
    Arch Dermatol; 2004 Feb; 140(2):160-2. PubMed ID: 14967786
    [No Abstract]   [Full Text] [Related]  

  • 23. Versajet hydroscalpel: treatment of diabetic foot ulceration.
    McCardle JE
    Br J Nurs; 2006 Aug 10-Sep 13; 15(15):S12-7. PubMed ID: 16936595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual reality pain control during burn wound debridement in the hydrotank.
    Hoffman HG; Patterson DR; Seibel E; Soltani M; Jewett-Leahy L; Sharar SR
    Clin J Pain; 2008 May; 24(4):299-304. PubMed ID: 18427228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Versajet hydrosurgery in burns wound debridement: a preliminary experience by Gravante G, Esposito G, Delogu D, Montone A. Burns 33;207:401-2.
    Jeffery SL
    Burns; 2007 Sep; 33(6):800. PubMed ID: 17656026
    [No Abstract]   [Full Text] [Related]  

  • 26. Versajet hydrosurgery system in the debridement of skin necrosis after Ca gluconate extravasation: report of 9 infantile cases.
    Sivrioğlu N; Irkören S
    Acta Orthop Traumatol Turc; 2014; 48(1):6-9. PubMed ID: 24643093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
    Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
    Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate skin grafting of sub-acute and chronic wounds debrided by hydrosurgery.
    Vanwijck R; Kaba L; Boland S; Gonzales y Azero M; Delange A; Tourbach S
    J Plast Reconstr Aesthet Surg; 2010 Mar; 63(3):544-9. PubMed ID: 19196559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrosurgery: alternative treatment technique for management of chronic osteomyelitis and septic arthritis of hallucial joint of a juvenile foot.
    Bhattacharyya M; Bradley H; Gerber BE
    Int J Low Extrem Wounds; 2010 Dec; 9(4):155-9. PubMed ID: 21134953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lyell's syndrome (toxic epidermal necrolysis)].
    Bruneau-Decelle N; Ledoux-Corbusier M
    Arch Belg Dermatol Syphiligr; 1969; 25(1):83-110. PubMed ID: 5400033
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids.
    Herndon DN
    J Am Coll Surg; 1995 Mar; 180(3):340-2. PubMed ID: 7874346
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxic epidermal necrolysis: a burn-centre challenge.
    Peters W; Zaidi J; Douglas L
    CMAJ; 1991 Jun; 144(11):1477-80. PubMed ID: 2032200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burn center care for patients with toxic epidermal necrolysis.
    Kelemen JJ; Cioffi WG; McManus WF; Mason AD; Pruitt BA
    J Am Coll Surg; 1995 Mar; 180(3):273-8. PubMed ID: 7874336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic epidermal necrolysis.
    Trans St Johns Hosp Dermatol Soc; 1967; 53(1):92-3. PubMed ID: 4865869
    [No Abstract]   [Full Text] [Related]  

  • 35. [Toxic Epidermal Necrolysis (Lyell syndrome): a pathology for burn units].
    Cabral L; Diogo C; Riobom F; Teles L; Cruzeiro C
    Acta Med Port; 2004; 17(2):129-40. PubMed ID: 15921643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toxic epidermal necrolysis, a life-threatening skin disease].
    Brouwer KJ; Boxma H; Dokter J
    Ned Tijdschr Geneeskd; 1994 Sep; 138(36):1819-22. PubMed ID: 7935909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A useful combination in the treatment of toxic epidermal necrolysis: Octenoidine dihydrocholoride solution and Aquacel-Ag.
    Coban YK; Erbatur S; Aytekin AH
    Burns; 2011 May; 37(3):545-6. PubMed ID: 21146312
    [No Abstract]   [Full Text] [Related]  

  • 39. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
    Yamada H; Takamori K
    Ther Apher Dial; 2008 Oct; 12(5):355-9. PubMed ID: 18937717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.